Muneeb Ullah | Nanomedicine | Innovator in Pharmaceutical Research Award

Published on by Top Pharmaceutical

Mr. Muneeb Ullah | Nanomedicine | Innovator in Pharmaceutical Research Award

Pusan National University | South Korea

Mr. Muneeb Ullah is a dedicated pharmaceutical scientist and research assistant at the Department of Pharmacy, Pusan National University, Busan, South Korea. His academic journey reflects a strong foundation in pharmaceutics, nanomedicine, and advanced drug delivery systems. With a Doctoral pursuit in Pharmacy at Pusan National University, his research focuses on nanoparticle preparation and novel therapeutic approaches for biofilm-associated wound healing, colon cancer, inflammatory bowel disease, and diabetic wound healing.Mr. Ullah’s earlier academic achievements include an MPhil in Pharmaceutical Sciences with a specialization in Pharmaceutical Nanotechnology from Kohat University of Science and Technology (KUST), Pakistan, where he conducted advanced research on the development of polymeric nanoparticles using the water-in-oil emulsion solvent evaporation method. His Pharm-D degree from KUST provided a robust grounding in pharmaceutics, pharmacology, biochemistry, and pharmaceutical chemistry, further shaping his expertise in nanotechnology-based therapeutics.Throughout his academic and professional career, he has demonstrated exceptional dedication and excellence. He has received several honors, including the Higher Education Commission Indigenous Scholarship, the Prime Minister Laptop Scheme’s Best Talent Award, the Best Teacher Award, and multiple Best Researcher Awards. His multidisciplinary experience includes teaching, research supervision, and laboratory expertise encompassing nanoparticle synthesis, animal handling for wound healing studies, HPLC, ELISA, UV spectrophotometry, zeta sizer analysis, and confocal microscopy.Mr. Ullah’s research contributions have significantly advanced the field of pharmaceutical nanotechnology. His publications span reputable journals and book chapters with publishers such as CRC Press and Academic Press. His works explore diverse topics, including genetic engineering of fungi, sugar nanocluster adhesives for diabetic wound healing, advancements in 3D and 4D bioprinting for sustained drug delivery, biomedical applications of carbon dots, tumor microenvironment biology, gastrointestinal inflammation, and nanoparticle-based oral cancer therapies. His studies on alginate-based tumor-selective nanoparticle delivery and cancer nanomedicine have been widely cited for their innovation and translational potential.To date, Mr. Ullah has contributed to 37 scholarly documents, amassing a total of 470 citations, with an h-index of 11, reflecting the influence and recognition of his research in the global scientific community. With this growing research impact, he continues to contribute to cutting-edge pharmaceutical research with a vision to design smarter, safer, and more efficient nanotherapeutics that bridge the gap between laboratory innovation and clinical application.

Profile: Scopus

Featured Publications

Author(s). (2025). Leukocyte esterase-activated nanoconjugates enables precise local therapy of ulcerative colitis via inflamed tissue-selective drug delivery. ACS Applied Materials and Interfaces.

Author(s). (2025). Sugar nanocluster adhesive boosts wound healing in diabetic mice. Carbohydrate Polymer Technologies and Applications.

Author(s). (2025). Genetic engineering of fungi.

Kleoniki Giannousi | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Kleoniki Giannousi | Nanomedicine | Best Researcher Award

Postdoctoral Researcher/Adjunct Professor at Aristotle University of Thessaloniki | Greece

Dr. Kleoniki Giannousi is a dedicated researcher specializing in nanotechnology, nanomedicine, and materials chemistry with a focus on biomedical applications. She earned her Ph.D. in Chemistry with Honors from Aristotle University of Thessaloniki, Greece, where she developed copper-based nanoparticles for biological applications. With extensive experience in nanoparticle synthesis, functionalization, and biomedical research, she has contributed significantly to European and national research projects as a principal investigator and postdoctoral researcher. Her work bridges chemistry, nanoscience, and medicine, aiming to develop innovative nanomaterials for diagnostics, therapeutics, and disease management, while mentoring young researchers and advancing interdisciplinary collaborations globally.

Publication Profile 

Orcid

Education 

Dr. Kleoniki Giannousi holds a Ph.D. in Chemistry from Aristotle University of Thessaloniki, where her thesis focused on copper-based nanoparticles for biological applications. She earned her M.Sc. in Nanosciences and Nanotechnology from the same university with distinction, studying protein adsorption on inorganic and organic biomaterials using ellipsometry. Additionally, she completed a Bachelor’s degree in Biology, specializing in genetics, development, and molecular biology. Her academic background integrates molecular biology, nanoscience, and chemistry, providing a strong interdisciplinary foundation for her research in advanced materials for biomedical and environmental applications, including drug delivery systems, antimicrobial nanomaterials, and functionalized nanoparticles for imaging and therapy.

 Experience 

Dr. Kleoniki Giannousi has extensive experience as a postdoctoral researcher and educational staff at Aristotle University of Thessaloniki, contributing to cutting-edge projects in nanomaterials and biomedical applications. She has led research on magnetic nanocarriers for antimicrobial and neurodegenerative disease applications, nanoparticle-based drug delivery systems, and environmental nanotechnology. Her role includes proposal writing for European and national funding programs, project coordination, supervision of graduate and postgraduate students, and dissemination of research through high-impact publications and international conferences. Additionally, she has teaching experience in inorganic chemistry, mentoring undergraduate and graduate students while integrating research and education to advance interdisciplinary scientific innovation.

Awards and Honors 

Dr. Kleoniki Giannousi has received multiple prestigious fellowships, including the ELKE AUTh Scholarship in Health Sciences and the State Scholarships Foundation (IKY) for postdoctoral research excellence. She was recognized as the top graduate in her M.Sc. program in Nanosciences and Nanotechnology. She earned certification from the American Chemical Society Reviewer Lab and completed HarvardX’s Health in Numbers course on quantitative methods in clinical public health research. Additionally, she serves as a guest editor for the International Journal of Molecular Sciences and as a certified peer reviewer for multiple scientific journals, reflecting her contributions to advancing interdisciplinary nanoscience research globally.

Research Focus 

Dr. Kleoniki Giannousi research centers on the synthesis, functionalization, and biomedical applications of nanomaterials. Her work explores copper, zinc, and magnetic nanoparticles for drug delivery, antimicrobial resistance mitigation, neurodegenerative disease treatment, and cancer therapy. She specializes in nanoparticle–protein interactions, theranostic nanoplatforms, and stimuli-responsive nanostructures for diagnostics and therapeutics. Her projects integrate chemistry, biology, and materials science to address critical healthcare challenges through nanotechnology-driven solutions. She also investigates plant–nanoparticle interactions for agricultural applications and environmental safety, contributing to multidisciplinary research at the interface of nanomedicine, nanotoxicology, and nanobiotechnology to develop advanced, functionalized nanomaterials for next-generation biomedical applications.

Publication Top Notes

Hani Serag | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Hani Serag | Nanomedicine | Best Researcher Award

Director, Division of Global Partnerships at University of Texas Medical Branch (UTMB) | United States

Dr. Hani Serag is a physician and public health specialist with extensive experience in health systems research, global health, and addressing health disparities. Currently serving as Director of the Division of Global Partnerships and Assistant Professor at the Department of Population Health and Health Disparities, University of Texas Medical Branch (UTMB), he leads multiple programs on chronic disease prevention, HIV screening, and global health diplomacy. With a strong history of academic, research, and policy leadership, Dr. Serag has collaborated with international organizations, academic institutions, and civil society networks to strengthen healthcare equity, health policy, and global partnerships.

Publication Profile 

Google Scholar

Education 

Dr. Hani Serag earned his MD (M.B., B.Ch) from the Faculty of Medicine, Ain Shams University, Cairo, Egypt. He holds a Master of Public Health (MPH) degree from the School of Public Health, University of Western Cape, South Africa, focusing on health systems research, monitoring and evaluation, health promotion, and primary healthcare. He further enhanced his expertise with advanced training in epidemiology, health care finance, biostatistics, and both quantitative and qualitative public health research methods through certificate programs at Erasmus University, Rotterdam, the Netherlands. His academic training integrates medicine, epidemiology, and public health with a global and systems-oriented perspective.

Experience 

Dr. Hani Serag has held key academic and leadership roles at UTMB, including Assistant Professor in Population Health and Endocrinology and Director of Global Partnerships. He has served as Principal Investigator for programs on chronic disease prevention, HIV screening, and international educational collaborations. His professional record includes consultancy and teaching engagements with the Pan American Health Organization (PAHO) and the World Health Organization (WHO). He previously served as Global Coordinator and Associate Global Coordinator for the People’s Health Movement, leading international initiatives on primary healthcare, social determinants of health, and global health governance. His work bridges academia, policy, and practice.

Awards and Honors 

Dr. Hani Serag contributions have been recognized through academic appointments across diverse disciplines including population health, internal medicine, pediatrics, and global health. His role as an Associate Member of the Graduate Faculty at UTMB highlights his mentorship of graduate students. He has been invited by WHO and PAHO for technical consultancies, curriculum development, and training programs, reflecting his international recognition in health systems and migration health research. Through his leadership in convening UTMB’s Annual Conference on Migration and Health and directing global health education initiatives, Dr. Serag has earned respect as a distinguished public health leader advancing health equity worldwide.

Research Focus 

Dr. Hani Serag research focuses on advancing health system responsiveness, reducing disparities, and integrating preventive care into clinical settings. His work emphasizes chronic disease prevention, HIV screening, and global health governance. He has designed and implemented multi-stakeholder programs that address the social determinants of health and promote patient-centered models of care. His scholarly contributions include health policy research, health systems evaluation, and migration and health studies. He has actively developed curricula, technical reports, and peer-reviewed publications to build capacity in health equity and health policy. His ongoing research strengthens global partnerships and evidence-based strategies in population health.

Publication Top Notes

Covid-19 pandemic and the social determinants of health

Explaining covid-19 performance: what factors might predict national responses?

High‐protein vs. standard‐protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro‐HEART trial

Improving the collection of race, ethnicity, and language data to reduce healthcare disparities: a case study from an academic medical center

Cultural diversity impacts caregiving experiences: a comprehensive exploration of differences in caregiver burdens, needs, and outcomes

Racial and geographic variation in leg amputations among Texans

Relative social standing and suicide ideation among Kenyan males: the interpersonal theory of suicide in context

Racial disparities in type of heart failure and hospitalization

Social determinants of health in countries in conflict and crises: the eastern Mediterranean perspective

Subjective social standing and conflict tactics among young Kenyan men

Illustrating the impact of commercial determinants of health on the global COVID-19 pandemic: Thematic analysis of 16 country case studies

Enabling structural resilience of street-involved children and youth in Kenya: reintegration outcomes and the Flourishing Community model

Understanding caregiver challenges: A comprehensive exploration of available resources to alleviate caregiving burdens

Coronavirus disease 2019, diabetes, and inflammation: A systemic review

Exploring the impact of ACA on rural‐urban disparity in oral health services among US noninstitutionalized adults

The association between mental well-being and school attendance among Palestinian adolescent refugees in UNRWA schools